Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07108868 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase I Dose Finding Study of MB-CART2219.1

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
A Phase I dose finding study of MB-CART2219.1 targeting CD19/CD22 in adult and pediatric patients with relapsed/refractory B-cell malignancies
Trial Details
NCT Number NCT07108868
Lead Sponsor University Hospital Tuebingen
Conditions
(from sponsor)
Lymphoma, CLL, Acute Lymphoblastic Leukemia, Pediatric
Related terms Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Enrollment 36 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov